IRVINE, Calif., – MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain, today announced that the neurological surgical team at University of Kansas Medical Center performed the first stereotactic laser ablation of the hippocampus (SLAH) procedure in their MRI suite, utilizing the ClearPoint Neuro Navigation System.
"We performed a successful stereotactic laser ablation on a 22 year old presenting with medically intractable seizures," said Dr. Paul J. Camarata, Associate Professor and Chairman of Vascular and Skull Base Neurosurgery. "Utilizing the ClearPoint System for this amygdalohippocampectomy allowed us to precisely, with sub-millimetric accuracy, provide this life changing treatment to our patient and improve her quality of life. The patient is still seizure free at 3 months," said Dr. Camarata.
The ClearPoint System is the only technology that enables minimally-invasive neurosurgery under continuous MRI guidance, offering surgeons real-time direction and a direct view of the inside of a patient's brain during a procedure. MRI provides superior visualization of the brain's tissue compared to other imaging technologies.
About MRI Interventions, Inc.
Building on the imaging power of MRI, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. The ClearPoint system, which has received 510(k) clearance and is CE marked, utilizes a hospital's existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit www.mriinterventions.com.
MRI Interventions, Inc.
Wendelin Maners, Vice President Marketing